{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:00:14Z","timestamp":1794002414235,"version":"4.8.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1245\/s10434-025-17321-w","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T14:54:39Z","timestamp":1747320879000},"page":"5063-5082","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS\/HIPEC) and Liver-Directed Therapy for Synchronous Peritoneal and Liver Metastatic Colorectal Cancer: A Systematic Review with Meta-analysis"],"prefix":"10.1245","volume":"32","author":[{"given":"Kadhim","family":"Taqi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simarpreet","family":"Icchhpuniani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecily","family":"Stockley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golpira Elmi","family":"Assadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Bouchard-Fortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"issue":"3","key":"17321_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3390\/cancers16030631","volume":"16","author":"MF Nielsen","year":"2024","unstructured":"Nielsen MF, Ravn S, S\u00f8rensen MM, et al. Recurrence and survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for synchronous and metachronous peritoneal metastases of colorectal origin. Cancers. 2024;16(3):631.","journal-title":"Cancers."},{"issue":"5","key":"17321_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.surge.2020.08.016","volume":"19","author":"M Flood","year":"2021","unstructured":"Flood M, Narasimhan V, Waters P, et al. Survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a systematic review and discussion of latest controversies. The Surgeon. 2021;19(5):310\u201320.","journal-title":"The Surgeon."},{"issue":"12","key":"17321_CR3","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the analysis and research in cancers of the digestive system (ARCAD) database. Lancet Oncol. 2016;17(12):1709\u201319.","journal-title":"Lancet Oncol."},{"issue":"20","key":"17321_CR4","first-page":"3737","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. Clin Oncol. 2003;21(20):3737\u201343.","journal-title":"Clin Oncol."},{"issue":"5","key":"17321_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/bjs5.50179","volume":"3","author":"S Hallam","year":"2019","unstructured":"Hallam S, Tyler R, Price M, et al. Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. BJS Open. 2019;3(5):585\u201394.","journal-title":"BJS Open."},{"issue":"2","key":"17321_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256\u201366.","journal-title":"Lancet Oncol."},{"issue":"11","key":"17321_CR7","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/codi.15003","volume":"22","author":"V Narasimhan","year":"2020","unstructured":"Narasimhan V, Tan S, Kong J, et al. Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis. Colorectal Dis. 2020;22(11):1482\u201395. https:\/\/doi.org\/10.1111\/codi.15003.","journal-title":"Colorectal Dis."},{"issue":"7","key":"17321_CR8","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.3390\/curroncol31070269","volume":"31","author":"K Taqi","year":"2024","unstructured":"Taqi K, Lee J, Hurton S, et al. Long-term outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Curr Oncol. 2024;31(7):3657\u201368.","journal-title":"Curr Oncol."},{"issue":"06","key":"17321_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1055\/s-0040-1714242","volume":"33","author":"H Yano","year":"2020","unstructured":"Yano H. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for peritoneal metastasis from colorectal cancer. Clin Colon Rectal Surg. 2020;33(06):372\u20136.","journal-title":"Clin Colon Rectal Surg."},{"issue":"16","key":"17321_CR10","first-page":"3284","volume":"22","author":"O Glehen","year":"2004","unstructured":"Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. Clin Oncol. 2004;22(16):3284\u201392.","journal-title":"Clin Oncol."},{"key":"17321_CR11","doi-asserted-by":"publisher","first-page":"1006591","DOI":"10.3389\/fsurg.2022.1006591","volume":"9","author":"S Di Carlo","year":"2022","unstructured":"Di Carlo S, Cavallaro G, La Rovere F, et al. Synchronous liver and peritoneal metastases from colorectal cancer: is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with liver resection a feasible option? Front Surg. 2022;9:1006591.","journal-title":"Front Surg."},{"issue":"4","key":"17321_CR12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/jso.24153","volume":"113","author":"Y Berger","year":"2016","unstructured":"Berger Y, Aycart S, Tabrizian P, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with liver involvement. J Surg Oncol. 2016;113(4):432\u20137.","journal-title":"J Surg Oncol."},{"issue":"1","key":"17321_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejso.2020.07.038","volume":"47","author":"RL Dico","year":"2021","unstructured":"Dico RL, Faron M, Yonemura Y, et al. Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol. 2021;47(1):89\u2013100.","journal-title":"Eur J Surg Oncol."},{"issue":"3","key":"17321_CR14","first-page":"249","volume":"11","author":"S El-Nakeep","year":"2017","unstructured":"El-Nakeep S, Rashad N, Oweira H, et al. Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review. Expert Rev Gastroenterol Hepatol. 2017;11(3):249\u201358.","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"17321_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1245\/s10434-006-9185-7","volume":"14","author":"J Esquivel","year":"2007","unstructured":"Esquivel J, Sticca R, Sugarbaker P, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Oncol. 2007;14:128\u201333.","journal-title":"Ann Surg Oncol."},{"key":"17321_CR16","unstructured":"Wells GA, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000. Available at: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"5","key":"17321_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.13105\/wjma.v3.i5.215","volume":"3","author":"T Greco","year":"2015","unstructured":"Greco T, Biondi-Zoccai G, Gemma M, et al. How to impute study-specific standard deviations in meta-analyses of skewed continuous endpoints? WJMA. 2015;3(5):215\u201324.","journal-title":"WJMA."},{"issue":"15","key":"17321_CR18","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1002\/cncr.24385","volume":"115","author":"O Varban","year":"2009","unstructured":"Varban O, Levine EA, Stewart JH, et al. Outcomes associated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in colorectal cancer patients with peritoneal surface disease and hepatic metastases. Cancer. 2009;115(15):3427\u201336.","journal-title":"Cancer."},{"issue":"12","key":"17321_CR19","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.ejso.2009.07.005","volume":"35","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Zhao J, et al. Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection. Eur J Surg Oncol. 2009;35(12):1299\u2013305.","journal-title":"Eur J Surg Oncol."},{"issue":"1","key":"17321_CR20","first-page":"116","volume":"258","author":"L Maggiori","year":"2013","unstructured":"Maggiori L, Go\u00e9r\u00e9 D, Viana B, et al. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study Ann Surg. 2013;258(1):116\u201321.","journal-title":"A case-control study. Ann Surg."},{"issue":"4","key":"17321_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/00015458.2015.11681109","volume":"115","author":"LF Abreu de Carvalho","year":"2015","unstructured":"Abreu de Carvalho LF, Scuderi V, Maes H, et al. Simultaneous parenchyma-preserving liver resection, cytoreductive surgery and intraperitoneal chemotherapy for stage IV colorectal cancer. Acta Chir Belg. 2015;115(4):261\u20137.","journal-title":"Acta Chir Belg"},{"issue":"11","key":"17321_CR22","doi-asserted-by":"publisher","first-page":"E167","DOI":"10.1111\/ans.13231","volume":"87","author":"N Alzahrani","year":"2017","unstructured":"Alzahrani N, Ung L, Valle SJ, et al. Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre. ANZ J Surg. 2017;87(11):E167\u201372.","journal-title":"ANZ J Surg."},{"key":"17321_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijsu.2015.11.025","volume":"25","author":"JB Delhorme","year":"2016","unstructured":"Delhorme JB, Dupont-Kazma L, Addeo P, et al. Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: Who will benefit from complete cytoreductive surgery? Int Surg J. 2016;25:98\u2013105.","journal-title":"Int Surg J."},{"issue":"4","key":"17321_CR24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ciresp.2017.03.003","volume":"95","author":"RM Morales Soriano","year":"2017","unstructured":"Morales Soriano RM, Canis JM, Romero XM, et al. Influence of simultaneous liver and peritoneal resection on postoperative morbi-mortality and survival in patients with colon cancer treated with surgical cytoreduction and intraperitoneal hyperthermic chemotherapy. Cir Esp. 2017;95(4):214\u201321.","journal-title":"Cir Esp."},{"key":"17321_CR25","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jss.2017.05.126","volume":"219","author":"S Downs-Canner","year":"2017","unstructured":"Downs-Canner S, Shuai Y, Ramalingam L, et al. Safety and efficacy of combined resection of colorectal peritoneal and liver metastases. J Surg Res. 2017;219:194\u2013201.","journal-title":"J Surg Res."},{"issue":"1","key":"17321_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejso.2016.09.010","volume":"43","author":"G Lorimier","year":"2017","unstructured":"Lorimier G, Linot B, Paillocher N, et al. Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer. EJSO. 2017;43(1):150\u20138.","journal-title":"EJSO."},{"key":"17321_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-019-1746-x","volume":"17","author":"Y Jeon","year":"2019","unstructured":"Jeon Y, Park EJ, Lim JH, et al. Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer. World J Surg Oncol. 2019;17:1\u201310.","journal-title":"World J Surg Oncol."},{"key":"17321_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00423-019-01787-w","volume":"404","author":"A Pinto","year":"2019","unstructured":"Pinto A, Hobeika C, Philis A, et al. Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: different strategies for curative treatment? Langenbecks Arch Surg. 2019;404:477\u201388.","journal-title":"Langenbecks Arch Surg."},{"issue":"1","key":"17321_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejso.2020.07.038","volume":"47","author":"R Lo Dico","year":"2021","unstructured":"Lo Dico R, Faron M, Yonemura Y, et al. Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol. 2021;47(1):89\u2013100. https:\/\/doi.org\/10.1016\/j.ejso.2020.07.038.","journal-title":"Eur J Surg Oncol."},{"key":"17321_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2021.101553","volume":"37","author":"MP Flood","year":"2021","unstructured":"Flood MP, Waters PS, Kelly ME, et al. Outcomes following synchronous liver resection, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases: a bi-institutional study. Surg Oncol. 2021;37:101553.","journal-title":"Surg Oncol."},{"key":"17321_CR31","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1245\/s10434-020-09165-3","volume":"28","author":"M Adileh","year":"2021","unstructured":"Adileh M, Mor E, Assaf D, et al. Perioperative and oncological outcomes of combined hepatectomy with complete cytoreduction and hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer. Ann Surg Oncol. 2021;28:3320\u20139.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"17321_CR32","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.3390\/jcm12113860","volume":"12","author":"R Morales-Soriano","year":"2023","unstructured":"Morales-Soriano R, Pine\u00f1o-Flores C, Mor\u00f3n-Canis JM, et al. Simultaneous surgical approach with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with concurrent peritoneal and liver metastases of colon cancer origin. J Clin Med. 2023;12(11):3860.","journal-title":"J Clin Med."},{"key":"17321_CR33","doi-asserted-by":"crossref","unstructured":"Balachandran R, S\u00f8rensen MM, Funder JA, et al. Outcomes after curatively intended treatment of limited peritoneal metastases and thermal ablation for liver metastases from colorectal cancer. Pleura Peritoneum. 2023; 8(4):167\u2013174","DOI":"10.1515\/pp-2023-0015"},{"issue":"4","key":"17321_CR34","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1245\/s10434-023-14840-2","volume":"31","author":"R Grange","year":"2024","unstructured":"Grange R, Rousset P, Williet N, et al. Metastatic colorectal cancer treated with combined liver resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy (HIPEC): predictive factors for early recurrence. Ann Surg Oncol. 2024;31(4):2378\u201390.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"17321_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg"},{"issue":"3","key":"17321_CR36","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1245\/s10434-021-10925-y","volume":"29","author":"MCE Polderdijk","year":"2022","unstructured":"Polderdijk MCE, Brouwer M, Haverkamp L, et al. Outcomes of combined peritoneal and local treatment for patients with peritoneal and limited liver metastases of colorectal origin: a systematic review and meta-analysis. Ann Surg Oncol. 2022;29(3):1952\u201362.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"17321_CR37","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/DCR.0000000000002027","volume":"64","author":"MP Flood","year":"2021","unstructured":"Flood MP, Das AA, Soucisse ML, et al. Synchronous liver and peritoneal metastases from colorectal cancer: is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with liver resection a feasible option? Dis Colon Rectum. 2021;64(6):754\u201364. https:\/\/doi.org\/10.1097\/DCR.0000000000002027.","journal-title":"Dis Colon Rectum."},{"key":"17321_CR38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1245\/s10434-006-9185-7","volume":"14","author":"J Esquivel","year":"2007","unstructured":"Esquivel J, Sticca R, Sugarbaker P, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Anna Surg Oncol. 2007;14:128\u201333.","journal-title":"Anna Surg Oncol."},{"key":"17321_CR39","doi-asserted-by":"publisher","first-page":"E2400306","DOI":"10.1200\/GO-24-00306","volume":"10","author":"S Patel","year":"2024","unstructured":"Patel S, Sheshadri RA, Saklani A, et al. INDEPSO-ISPSM consensus on peritoneal malignancies: management of colorectal peritoneal metastases. JCO Glob Oncol. 2024;10:E2400306.","journal-title":"JCO Glob Oncol."},{"issue":"11","key":"17321_CR40","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1002\/cncr.32874","volume":"126","author":"Chicago Consensus Working Group","year":"2020","unstructured":"Chicago Consensus Working Group. The Chicago consensus on peritoneal surface malignancies: management of colorectal metastases. Cancer. 2020;126(11):2534\u201340. https:\/\/doi.org\/10.1002\/cncr.32874.","journal-title":"Cancer"},{"issue":"1","key":"17321_CR41","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1245\/s10434-015-4627-8","volume":"23","author":"M Faron","year":"2016","unstructured":"Faron M, Macovei R, Go\u00e9r\u00e9 D, et al. Linear relationship of peritoneal cancer index and survival in patients with peritoneal metastases from colorectal cancer. Ann Surg Oncol. 2016;23(1):114\u20139. https:\/\/doi.org\/10.1245\/s10434-015-4627-8.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"17321_CR42","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1200\/JCO.1997.15.3.938","volume":"15","author":"Y Fong","year":"1997","unstructured":"Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol. 1997;15(3):938\u201346.","journal-title":"J Clin Oncol"},{"issue":"6","key":"17321_CR43","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.surg.2011.12.018","volume":"151","author":"D Quan","year":"2012","unstructured":"Quan D, Gallinger S, Nhan C, et al. The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: a systematic review. Surgery. 2012;151(6):860\u201370.","journal-title":"Surgery."},{"issue":"10","key":"17321_CR44","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1245\/s10434-024-15694-y","volume":"31","author":"RI Ayabe","year":"2024","unstructured":"Ayabe RI, Beaty K, Newhook TE, et al. Incomplete cytoreduction and need for major hepatectomy predict shorter survival in patients undergoing combined cytoreductive surgery and hepatectomy for metastatic colorectal cancer. Ann Surg Oncol. 2024;31(10):6366\u20138. https:\/\/doi.org\/10.1245\/s10434-024-15694-y.","journal-title":"Ann Surg Oncol."},{"key":"17321_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114160","volume":"207","author":"R Cohen","year":"2024","unstructured":"Cohen R, Raeisi M, Chibaudel B, et al. Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: an ARCAD pooled analysis. Eur J Cancer. 2024;207:114160. https:\/\/doi.org\/10.1016\/j.ejca.2024.114160.","journal-title":"Eur J Cancer."},{"key":"17321_CR46","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2147\/cmar.s355318","volume":"14","author":"CC Li","year":"2022","unstructured":"Li CC, Chang TK, Chen YC, et al. Clinical outcomes of patients with peritoneal metastasis-only colorectal cancer treated with first-line bevacizumab and folfiri through irinotecan dose escalation according to ugt1a1 polymorphism: compared to liver metastasis-only, and lung metastasis-only. Cancer Manag Res. 2022;14:1541\u20139. https:\/\/doi.org\/10.2147\/cmar.s355318.","journal-title":"Cancer Manag Res."},{"issue":"14","key":"17321_CR47","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa0805019","volume":"360","author":"E Van Cutsem","year":"2009","unstructured":"Van Cutsem E, K\u00f6hne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009;360(14):1408\u201317.","journal-title":"N Engl J Med."},{"key":"17321_CR48","doi-asserted-by":"publisher","first-page":"1006591","DOI":"10.3389\/fsurg.2022.1006591","volume":"9","author":"S Di Carlo","year":"2022","unstructured":"Di Carlo S, Cavallaro G, La Rovere F, et al. Synchronous liver and peritoneal metastases from colorectal cancer: is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with liver resection a feasible option? Front Surg. 2022;9:1006591. https:\/\/doi.org\/10.3389\/fsurg.2022.1006591.","journal-title":"Front Surg."},{"issue":"9","key":"17321_CR49","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1007\/s11605-018-3784-z","volume":"22","author":"JM Cloyd","year":"2018","unstructured":"Cloyd JM, Abdel-Misih S, Hays J, et al. Impact of synchronous liver resection on the perioperative outcomes of patients undergoing CRS-HIPEC. J Gastrointest Surg. 2018;22(9):1576\u201384.","journal-title":"J Gastrointest Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17321-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17321-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17321-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:58:35Z","timestamp":1748869115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17321-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["17321"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17321-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Kadhim Taqi, Simarpreet Icchhpuniani, Cecily Stockley, Golpira Elmi Assadzadeh, Elijah Dixon, Lloyd Mack, and Antoine Bouchard-Fortier declare no relevant affiliations or financial interests in the subject matter or materials discussed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}